Biocon Limited (BIOCON.NS)

295.05 -5.55 (-1.85%) At close: 03:29PM IST

Biocon Limited

20th KM, Hosur Road
Electronic City
Bengaluru 560100
India
91 80 2808 2808
https://www.biocon.com

Sector(s): Healthcare
Industry: Biotechnology
Full-time employees: 16,545

Key executives

Name	Title	Pay	Exercised	Year born
Ms. Kiran Mazumdar-Shaw B.Sc (Hons), B.Sc.	Founder & Executive Chairperson	30M	N/A	1953
Mr. Siddharth Mittal BCom, CA, CPA	MD, CEO & Director	47.88M	N/A	1978
Mr. Peter James Jonathan Bains	Group Chief Executive Officer	3.28M	N/A	1957
Mr. Arun Gupta	Head of Operations	N/A	N/A	N/A
Mr. Atanu Roy	Group Chief Information Officer	N/A	N/A	N/A
Mr. Saurabh Paliwal	Head of Investor Relations	N/A	N/A	N/A
Mr. Mayank Verma	Company Secretary & Compliance Officer	5.75M	N/A	N/A
Ms. Seema Shah Ahuja BA, MBA	Global Head of Communications & Corporate Brand	N/A	N/A	1966
Ms. Maninder Kapoor Puri	Head of Human Resources	N/A	N/A	1973
Mr. Paul Vazhayil Thomas	Chief Commercial Officer, U.S. & Portfolio Strategy & Business Dev, Adv mkts of Biosimilars Business	N/A	N/A	1973

Amounts are as of 31 December 2023, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in INR.

Description

Biocon Limited, a biopharmaceutical company, manufactures pharmaceuticals, and medicinal chemical and botanical products. The company operates through Generics, Novel Biologics, Biosimilars, and Research Services segments. It focuses in the areas of diabetes, oncology, immunology, ophthalmology, and bone health diseases. In addition, the company is involved in the integrated discovery, development, and manufacturing services for small and large molecules. It serves customers in approximately 120 countries. The company was incorporated in 1978 and is headquartered in Bengaluru, India.

Corporate governance

Biocon Limited’s ISS governance QualityScore as of 1 May 2024 is 4. The pillar scores are Audit: 7; Board: 2; Shareholder rights: 1; Compensation: 9.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.